⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMIX News
Autonomix Medical, Inc. Common Stock
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026
globenewswire.com
AMIX
Autonomix Medical to Present at LSI USA ’26
globenewswire.com
AMIX
Autonomix Medical Selected for Best Innovation Competition at CRT 2026
globenewswire.com
AMIX
Autonomix Medical Selected for Best Innovation Competition at CRT 2026
globenewswire.com
AMIX
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis
globenewswire.com
AMIX
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation
globenewswire.com
AMIX
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
globenewswire.com
AMIX
Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meeting
globenewswire.com
AMIX
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium
globenewswire.com
AMIX
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
globenewswire.com
AMIX